[1]
Mendes, I.C.M. et al. 2024. Myelotoxicity and kidney dysfunction related to the use of trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia: a case report of severe adverse events with a common drug. Revista do Instituto de Medicina Tropical de São Paulo. 66, (Mar. 2024), e18. DOI:https://doi.org/10.1590/.